Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 16044144)

Published in Bone Marrow Transplant on September 01, 2005

Authors

G de Lissovoy1, D Hurd, S Carter, P Beatty, M Ewell, J Henslee-Downey, N Kernan, S Yanovich, D Weisdorf

Author Affiliations

1: MEDTAP International Incorporated, Center of Health Economics, Bethesda, MD 20814, USA. deLissovoy@medtap.com

Associated clinical trials:

T-Cell Depletion in Unrelated Donor Marrow Transplantation | NCT00000591

Articles by these authors

1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med (1999) 5.82

Alternative definitions of disability: relationship to health-care expenditures. Disabil Rehabil (1997) 5.50

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood (2001) 3.32

Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nat Genet (1999) 3.25

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med (1986) 3.22

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med (1993) 2.85

A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood (1995) 2.83

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood (1998) 2.76

Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol (1997) 2.66

T lymphocyte adhesion to endothelial cells: mechanisms demonstrated by anti-LFA-1 monoclonal antibodies. J Immunol (1986) 2.28

Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood (1999) 2.22

Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood (1996) 2.19

Natural history of acute hemiplegia of childhood. Brain (1970) 2.14

Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood (1990) 2.09

Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma. J Clin Oncol (1997) 2.02

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant (2001) 2.00

Injuries in Australian cricket at first class level 1995/1996 to 2000/2001. Br J Sports Med (2002) 1.74

Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J (1974) 1.69

Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum. Neuropathol Appl Neurobiol (2010) 1.65

Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood (1989) 1.65

Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood (1991) 1.61

A mobile-bearing total knee prosthesis compared with a fixed-bearing prosthesis. A multicentre single-blind randomised controlled trial. J Bone Joint Surg Br (2003) 1.60

Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial. Br J Haematol (1989) 1.57

Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV. Bone Marrow Transplant (1999) 1.56

Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis (1999) 1.55

The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man. Clin Pharmacol Ther (1970) 1.54

Reconstruction with rectus abdominis myocutaneous free flap after orbital exenteration in children. Arch Ophthalmol (2001) 1.53

Acute upper respiratory tract viral illness and influenza immunization in homes for the elderly. Epidemiol Infect (1990) 1.49

A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia. J Urol (2001) 1.49

A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease. Biol Blood Marrow Transplant (2000) 1.48

Assessing the health risks of benzene: a report on the benzene state-of-the-science workshop. J Toxicol Environ Health A (2000) 1.45

Public accountability: one rule for practitioners, one for scientists? J Health Serv Res Policy (2001) 1.42

Characteristics of adolescent hallux abducto valgus. A retrospective review. J Am Podiatr Med Assoc (1994) 1.42

Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med (1986) 1.41

Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691. Leuk Lymphoma (2009) 1.39

Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells. Blood (1998) 1.39

In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation. J Immunother (2001) 1.38

GO GIRLS!: results from a nutrition and physical activity program for low-income, overweight African American adolescent females. Health Educ Behav (2000) 1.34

Double-blind study of the effects of dexamethasone on acute stroke. Neurology (1972) 1.33

Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer. J Clin Oncol (1996) 1.31

Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood (1986) 1.30

Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group. Transplantation (1999) 1.29

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience. Blood (2001) 1.27

Peri-acetabular resection and endoprosthetic reconstruction for tumours of the acetabulum. J Bone Joint Surg Br (2008) 1.25

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood (2001) 1.22

Abundance, diversity, and patterns of distribution of primates on the Tapiche River in Amazonian Peru. Am J Primatol (2001) 1.21

Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet (2000) 1.20

Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant (2012) 1.17

Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood (2001) 1.16

The biology of human immunodeficiency virus-1 IIIB infection in the chimpanzee: in vivo and in vitro correlations. J Med Primatol (1989) 1.15

Biochemical markers in bronchial carcinoma. Br J Cancer (1977) 1.12

Effect of infusion rate on amphotericin B-associated febrile reactions. Drug Intell Clin Pharm (1988) 1.12

Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood (1995) 1.12

Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol (1997) 1.11

The critically ill child: management of status epilepticus. Pediatrics (1969) 1.11

Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant (1997) 1.11

Reflux gastritis syndrome: mechanism of symptoms. Gastroenterology (1980) 1.09

Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 1.09

Characteristics of males at a public health department contraceptive service. J Adolesc Health Care (1989) 1.08

Streptococcal sepsis in bone marrow transplant patients. Lancet (1984) 1.08

Hemostasis of punctured blood vessels using high-intensity focused ultrasound. Ultrasound Med Biol (1998) 1.07

Serum antibody response to oral infection precedes but does not prevent Porphyromonas gingivalis-induced alveolar bone loss in mice. Oral Microbiol Immunol (1999) 1.07

Immunologic effects of interleukin 2 in primary immunodeficiency diseases. J Immunol (1983) 1.06

Continuous 5-fluorouracil infusion in refractory carcinoma of the breast. Breast Cancer Res Treat (1987) 1.05

Liver hemostasis using high-intensity focused ultrasound. Ultrasound Med Biol (1997) 1.05

Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation. Am J Med (1990) 1.04

Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant (1994) 1.03

Congenital hyperammonemia. Association with hyperglycinemia and decreased levels of carbamyl phosphate synthetase. Arch Neurol (1970) 1.03

Auto-SCT for AML in second remission: CALGB study 9620. Bone Marrow Transplant (2009) 1.03

Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease. Transplantation (1991) 1.03

Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium. Bone Marrow Transplant (2013) 1.02

To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century. Bone Marrow Transplant (2013) 1.01

Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. Blood (2000) 1.01

Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med (1987) 1.01

Use of high-intensity focused ultrasound to control bleeding. J Vasc Surg (1999) 1.00

Muscle sense in man. Exp Neurol (1967) 1.00

Four new recurring translocations in non-Hodgkin lymphoma. Blood (1989) 1.00

Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy. Transplantation (1993) 0.99

Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival. Bone Marrow Transplant (2010) 0.99

Vascular outcome in men with asymptomatic retinal cholesterol emboli. A cohort study. Ann Intern Med (1995) 0.98

Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. Leukemia (2009) 0.98

A custom-made prosthesis attached to an existing femoral component for the treatment of peri- and sub-prosthetic fracture. J Bone Joint Surg Br (2006) 0.98

Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. Blood (1987) 0.98

Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation. Bone Marrow Transplant (2009) 0.97

Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Leukemia (2010) 0.97

Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement. Blood (1985) 0.97

Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study. J Neurol Neurosurg Psychiatry (1998) 0.96

Preparation and interaction of a low-density lipoprotein:daunomycin complex with P388 leukemic cells. Cancer Res (1984) 0.96

Duration of diastole versus cycle length as correlates of left ventricular ejection time. Br Heart J (1976) 0.96

Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity. Biol Blood Marrow Transplant (1997) 0.95

Anatomic basis for individuated surface EMG and homogeneous electrostimulation with neuroprostheses of the extensor digitorum communis. J Neurophysiol (2008) 0.95

Met receptor dynamics and signalling. Curr Top Microbiol Immunol (2004) 0.94

Magnetic resonance imaging of cardiac rhabdomyosarcoma. Quantifying the response to chemotherapy. Cancer (1991) 0.94

Inference using conditional logistic regression with missing covariates. Biometrics (1998) 0.94

Translocation of a hydrocarbon fluorescent probe between Epstein-Barr virus and lymphoid cells: an assay for early events in viral infection. Proc Natl Acad Sci U S A (1978) 0.94

The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients. Bone Marrow Transplant (1990) 0.93

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML. Bone Marrow Transplant (2013) 0.93